These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28468085)

  • 1. [How I treat myelodysplastic symdromes].
    Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2017 Apr; 38(4):268-271. PubMed ID: 28468085
    [No Abstract]   [Full Text] [Related]  

  • 2. NPM1 mutations in myelodysplastic syndromes and acute myeloid leukemia with normal karyotype.
    Zhang Y; Zhang M; Yang L; Xiao Z
    Leuk Res; 2007 Jan; 31(1):109-11. PubMed ID: 16678898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enasidenib in patients with mutant IDH2 myelodysplastic syndromes: a phase 1 subgroup analysis of the multicentre, AG221-C-001 trial.
    Stein EM; Fathi AT; DiNardo CD; Pollyea DA; Roboz GJ; Collins R; Sekeres MA; Stone RM; Attar EC; Frattini MG; Tosolini A; Xu Q; See WL; MacBeth KJ; de Botton S; Tallman MS; Kantarjian HM
    Lancet Haematol; 2020 Apr; 7(4):e309-e319. PubMed ID: 32145771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Luspatercept for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes (PACE-MDS): a multicentre, open-label phase 2 dose-finding study with long-term extension study.
    Platzbecker U; Germing U; Götze KS; Kiewe P; Mayer K; Chromik J; Radsak M; Wolff T; Zhang X; Laadem A; Sherman ML; Attie KM; Giagounidis A
    Lancet Oncol; 2017 Oct; 18(10):1338-1347. PubMed ID: 28870615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infections in myelodysplastic syndromes.
    Toma A; Fenaux P; Dreyfus F; Cordonnier C
    Haematologica; 2012 Oct; 97(10):1459-70. PubMed ID: 22733024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation induction therapy of myelodysplastic syndromes.
    Hassan HT; Rees J
    Leuk Res; 1989; 13(7):633-7. PubMed ID: 2668648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Darbepoetin alfa for anemia with myelodysplastic syndrome.
    Seastone DJ; Gerds AT
    Expert Rev Hematol; 2015 Apr; 8(2):139-46. PubMed ID: 25579702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential azacitidine and lenalidomide in patients with high-risk myelodysplastic syndromes and acute myeloid leukaemia: a single-arm, phase 1/2 study.
    DiNardo CD; Daver N; Jabbour E; Kadia T; Borthakur G; Konopleva M; Pemmaraju N; Yang H; Pierce S; Wierda W; Bueso-Ramos C; Patel KP; Cortes JE; Ravandi F; Kantarjian HM; Garcia-Manero G
    Lancet Haematol; 2015 Jan; 2(1):e12-20. PubMed ID: 26687423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of recombinant human erythropoietin to treat the anemia of myelodysplastic syndromes.
    Greenberg PL
    Semin Hematol; 1993 Oct; 30(4 Suppl 6):22-4. PubMed ID: 8153674
    [No Abstract]   [Full Text] [Related]  

  • 10. Recombinant erythropoietin in myelodysplastic syndromes: whom to treat and how? More questions than answers.
    Mittelman M
    Acta Haematol; 1993; 90(2):53-7. PubMed ID: 8285018
    [No Abstract]   [Full Text] [Related]  

  • 11. Sotatercept with long-term extension for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes: a phase 2, dose-ranging trial.
    Komrokji R; Garcia-Manero G; Ades L; Prebet T; Steensma DP; Jurcic JG; Sekeres MA; Berdeja J; Savona MR; Beyne-Rauzy O; Stamatoullas A; DeZern AE; Delaunay J; Borthakur G; Rifkin R; Boyd TE; Laadem A; Vo B; Zhang J; Puccio-Pick M; Attie KM; Fenaux P; List AF
    Lancet Haematol; 2018 Feb; 5(2):e63-e72. PubMed ID: 29331635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of bone marrow microenvironment could change how myelodysplastic syndromes are diagnosed and treated.
    Aanei CM; Catafal LC
    Cytometry A; 2018 Jul; 93(9):916-928. PubMed ID: 30211968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial.
    Platzbecker U; Della Porta MG; Santini V; Zeidan AM; Komrokji RS; Shortt J; Valcarcel D; Jonasova A; Dimicoli-Salazar S; Tiong IS; Lin CC; Li J; Zhang J; Giuseppi AC; Kreitz S; Pozharskaya V; Keeperman KL; Rose S; Shetty JK; Hayati S; Vodala S; Prebet T; Degulys A; Paolini S; Cluzeau T; Fenaux P; Garcia-Manero G
    Lancet; 2023 Jul; 402(10399):373-385. PubMed ID: 37311468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myelodysplastic syndromes should been renamed as myelodysplastic neoplasms.
    Li Y; Lin P; Ge Y; Garcia-Manero G
    Leuk Res; 2013 Apr; 37(4):463-4. PubMed ID: 23347902
    [No Abstract]   [Full Text] [Related]  

  • 15. Infection control in patients with myelodysplastic syndromes who are candidates for active treatment: Expert panel consensus-based recommendations.
    Girmenia C; Candoni A; Delia M; Latagliata R; Molteni A; Oliva EN; Palumbo GA; Poloni A; Salutari P; Santini V; Voso MT; Musto P
    Blood Rev; 2019 Mar; 34():16-25. PubMed ID: 30448050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smoking and myelodysplastic syndromes.
    Björk J; Albin M; Mauritzson N; Strömberg U; Johansson B; Hagmar L
    Epidemiology; 2000 May; 11(3):285-91. PubMed ID: 10784245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myelodysplastic syndromes.
    Scott BL; Deeg HJ
    Annu Rev Med; 2010; 61():345-58. PubMed ID: 20059342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biology of the bone marrow microenvironment and myelodysplastic syndromes.
    Rankin EB; Narla A; Park JK; Lin S; Sakamoto KM
    Mol Genet Metab; 2015; 116(1-2):24-8. PubMed ID: 26210353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosis.
    Thol F; Weissinger EM; Krauter J; Wagner K; Damm F; Wichmann M; Göhring G; Schumann C; Bug G; Ottmann O; Hofmann WK; Schlegelberger B; Ganser A; Heuser M
    Haematologica; 2010 Oct; 95(10):1668-74. PubMed ID: 20494930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on blood and bone marrow findings of myelodysplastic syndromes: evaluation of proposals for classification of myelodysplastic syndromes.
    Yang CL; Li LQ; Chen WJ; Yang TY; Sun YM; Li XY
    Proc Chin Acad Med Sci Peking Union Med Coll; 1988; 3(1):7-11. PubMed ID: 3174618
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.